MRI: Page 471

IMRIS wins Chinese contract for MR suite

By AuntMinnie.com staff writers

Canadian intraoperative MRI developer IMRIS has placed its IMRIS intraoperative MRI system in a Beijing hospital, the Winnipeg, Manitoba-based firm reported.

January 31, 2008

Epix reaches agreement with FDA over Vasovist

By AuntMinnie.com staff writers

MRI contrast developer Epix Pharmaceuticals of Lexington, MA, has reached an agreement with the U.S. Food and Drug Administration (FDA) on a proposal to reread images collected in trials of its blood-pool MR angiography agent, Vasovist, the company reported.

January 31, 2008

SWI MR reveals microarchitecture of neurovascular diseases

By E. Mark Haacke, Ph.D.

In 2004 E. Mark Haacke, Ph.D., from Detroit's Wayne State University, discussed his work with susceptibility-weighted imaging (SWI) during a lecture at the San Francisco VA Medical Center. Haacke returns with an update on the applications of SWI in neuroimaging, including exciting advances in understanding Alzheimer's disease, stroke, and trauma. Haacke and colleagues have also launched a new database to showcase exceptional SWI cases.

January 31, 2008

2008 01 25 15 57 08 706

Total tumor biology impacts cervical cancer regression during EBRT

By Shalmali Pal

Cervical tumor volume may be an insufficient marker for changes during fractionated radiotherapy, according to a study in the January issue of the International Journal of Radiation Oncology, Biology, Physics. Instead, researchers from Toronto have developed a multivariate strategy to better predict tumor response during treatment.

January 29, 2008

Tesla wars: MRI strikes back with monster magnets

By Robert Junk and Tobias Gilk

The CT slice wars are sooo last year. Welcome to the tesla wars. MRI architectural consultants Tobias Gilk and Robert Junk of MRI-Planning.com take a look at the rise of increasingly higher field strength magnets -- we're talking 11.7-tesla systems -- and why they may be coming soon to a hospital near you.

January 28, 2008

Medtronic to begin testing MRI-safe pacemaker

By AuntMinnie.com staff writers

Interventional technology firm Medtronic has begun a U.S. clinical trial to confirm the safety and efficacy of its EnRhythm MRI SureScan pacing system.

January 27, 2008

Toshiba gets clearance for Titan MRI scanner

By AuntMinnie.com staff writers

Toshiba America Medical Systems has received U.S. Food and Drug Administration clearance for its open-bore 1.5-tesla Vantage Titan MR scanner.

January 27, 2008

London center opens with Siemens scanners

By AuntMinnie.com staff writers

Great Ormond Street Hospital for Children in London has officially opened its new state-of-the-art MR & CT Imaging Centre. The new center has been equipped with imaging technologies from Siemens Healthcare.

January 27, 2008

AuntMinnie.com MRI Insider

By Shalmali Pal

January 27, 2008

Study offers more evidence that multiple factors up NSF risk

By Shalmali Pal

Gadolinium-based contrast agents may not be the only culprit in the development of nephrogenic systemic fibrosis (NSF), and a new case report from the University of Texas in Galveston supports that theory. This multispecialty group reviewed a decade's worth of data, taking into consideration contrast-enhanced MR studies as well as a broad range of other risk factors.

January 23, 2008

Invivo aids in conjoined twin procedure

By AuntMinnie.com staff writers

Orlando, FL-based Invivo had a hand in last year's study to surgically separate a pair of conjoined twins at the Lucile Packard Children's Hospital at the Stanford University Medical Center in Stanford, CA.

January 22, 2008

'Uniquely higher' relaxivity rates give gadobenate an edge

By Shalmali Pal

Not all gadolinium-based agents are created equal, and those agents with a higher relaxivity point offer a number of advantages in clinical MRI, according to a study in the American Journal of Neuroradiology. In this in vitro study, the investigators from the University of Pittsburgh in Pennsylvania demonstrated differences among various gadolinium-based contrast agents.

January 22, 2008

Page 471 of 625